 Nigeria, the most populous country in Africa, has one of the greatest incidences of mortality rates in the continent, with an estimated 15,000 cases and 10,000 deaths annually. cervical cancer is a major public problem in Africa, where it is the cause of cancer deaths among women. According to the World Health Organization, about 119,000 new cases and 81,000 deaths from cervical cancer in Africa in 2020, accounting for the global burden. There is therefore an urgent need for effective and sustainable ways to prevent and control cervical cancer in Nigeria and other African countries. Garasil is a vaccine that protects human papillomavirus, a sexually transmitted infection that cervical vaginal vulva and other diseases recommended for girls and boys 12 years, but can be given as early as, can be given to as late as 26 years old. I'm going to continue to have engagement internally with CBA, Federal Ministry of Finance, Customs, NAQS, and externally with European Union. With European Union, we are already getting some results. The EU has reduced the inspection of melons from 100% to 50%. We're not there yet, but it's better than 100% all the time. In the interim, I implore all Nigerian exporters trading in NAVDAC regulated products to obtain necessary certifications for processing of their products. The National Primary Health Care Development Agency comments the introduction of the use of code-revalent Garasil single-dose schedule into a routine immunization in Nigeria in 2023. The decision to deploy the off-label as a single-dose schedule is based on scientific evidence that shows that a dose of Garasil vaccine can protect against cervical cancer. Human papillomavirus NAVDAC is in support of these data from immunogenic CTC trials, analysis of efficacy trials, and post-observation studies among demonstrated and single dose of vaccine is sufficient to elicit a response that provides similar and a multi-dose regime against initial persistent HPV infection. I am delighted to stand here with the DG of NAVDAC and our partners and donors to share that this vaccine will be provided free of charge to all eligible girls in Nigeria commencing on October 24, 2023. Alongside our partners and donors, we have secured over 6 million doses of the HPV vaccine and essential supplies. We have conducted numerous fora to raise awareness among stakeholders, including parents and caregivers regarding the pivotal importance of HPV vaccination. To address any concerns or misconceptions, we have engaged with communities and established a robust monitoring and evaluation framework to measure the impact and progress of the vaccination campaign. Hello, hope you enjoyed the news. Please do subscribe to our YouTube channel and don't forget to hit the notification button so you get notified about fresh news updates.